Robotic mitral valve surgery in Latin America

Rheumatic heart disease remains the leading cause of mitral valve (MV) disease in developing countries (1). In Latin America, with population aging and socio economical development in the past decades, degenerative disease of the MV has become increasingly prevalent (2). Both rheumatic and degenerative disease can lead to severe MV dysfunction, often requiring surgical intervention.

Publicação